info@carbon-zero.uk | BOOK A CONSULTATION

Macomics Ltd – Carbon Assessment and Reduction Plan

Client: Macomics Ltd

Sector: Biotech / Drug Discovery

Services: Carbon Assessment and Reduction Plan

Macomics is a macrophage drug discovery company using its validated ENIGMAC™ platform to create genetic models of disease, uncover novel therapeutic targets, and progress new treatments where current options are limited or ineffective.

To strengthen ESG reporting and integrate sustainability into operations, Macomics engaged Carbon Zero to baseline its greenhouse gas (GHG) emissions and develop a practical Carbon Reduction Plan.

Objectives

Independently assess operational GHG emissions (Scopes 1–2 and material Scope 3 categories)
Identify opportunities for credible emissions reduction
Prepare a strategic, measurable Carbon Reduction Plan

Results

Completed a comprehensive carbon assessment across Macomics’ UK sites and key value-chain activities
Produced a detailed Carbon Reduction Plan aligned with recognised best practice and suitable for stakeholder reporting

Value To Client

With Carbon Zero’s support, Macomics has:

Quantified its operational carbon footprint as a baseline for tracking progress
Identified priority reduction levers (facilities, procurement, travel, labs)
Established a clear plan to cut emissions in line with business growth and stakeholder expectations

“Carbon Zero were professional, supportive and highly knowledgeable throughout the process. Their guidance helped us better understand our operational emissions and identify meaningful opportunities for reduction. We found the experience both valuable and educational.”